Latest 10-K annual reports

VoIP-Pal.Com Inc. filed its annual 10-K, revealing a net loss of $6.2 million, an accumulated deficit exceeding $109 million, and significant going concern uncertainties, despite reduced operating expenses.

Texas Mineral Resources Corp. files an amended annual report to update corporate governance, executive compensation, and related party transaction disclosures for the fiscal year ended August 31, 2025.

Citius Pharmaceuticals, Inc. reports a net loss of $39.7 million for fiscal year 2025, with its subsidiary Citius Oncology launching LYMPHIR amidst ongoing funding needs and product development.

Citius Oncology launched its lead product LYMPHIR in December 2025, but faces substantial doubt about its ability to continue as a going concern due to recurring losses and a need for significant additional funding.

Barnwell Industries reported a significant net loss for fiscal year 2025, driven by decreased oil and natural gas revenues, asset sales, and substantial legal expenses, despite a recent capital raise.

Limoneira Company reported a significant net loss for fiscal year 2025, driven by decreased agribusiness revenue and strategic operational changes, while advancing real estate projects and debt restructuring.

Collab Z Inc. reported a net loss of $102,195 for fiscal year 2025, a significant decline from the prior year's net income, as it pivots to its AI-enhanced community-based property management platform and phases out other real estate services.

Innovative Solutions and Support, Inc., now Innovative Aerosystems, reported significant revenue and net income growth for fiscal year 2025, driven by strategic acquisitions and commercial expansion.

Barnes & Noble Education, Inc. files its restated annual report, revealing financial adjustments, growth in affordable course material programs, and significant governance and financing changes.

HEICO Corporation achieved record net sales of $4.485 billion and net income of $690.4 million in fiscal 2025, reflecting strong organic growth and strategic acquisitions across its Flight Support and Electronic Technologies segments.

Hovnanian Enterprises reports a significant decrease in net income and gross margin for fiscal 2025 despite increased home deliveries, driven by higher incentives and debt extinguishment losses.

enGene Holdings Inc. reported increased net losses for fiscal year 2025 while advancing its lead bladder cancer therapy, detalimogene, towards a planned BLA submission in late 2026.

SIFCO Industries, Inc. significantly narrowed its net loss in fiscal year 2025, driven by increased sales in aerospace and energy, improved margins, and a strategic divestiture of its European operations.

Synopsys achieved 15% revenue growth in fiscal 2025, driven by the Ansys acquisition and Design Automation strength, despite Design IP weakness and increased debt.

BNB Plus Corp. (formerly Applied DNA Sciences, Inc.) has completed a strategic pivot to a digital asset treasury model focused on BNB, while reporting a significantly wider net loss for fiscal year 2025.

Agilent Technologies achieved 7% net revenue growth in fiscal year 2025, reaching $6.95 billion, driven by strong performance in Life Sciences and Diagnostics Markets, alongside strategic restructuring and share repurchases.

Mercer Bancorp, Inc. reported a 40.4% increase in net income for fiscal year 2025, reaching $972,000, despite a notable rise in non-performing loans.

Outlook Therapeutics received a second Complete Response Letter from the FDA for its wet AMD treatment, ONS-5010/LYTENAVA, citing insufficient evidence of effectiveness, despite recent EU and UK market authorizations.

Flanigan's Enterprises, Inc. announced a 9.63% increase in total revenue to $205.2 million and a 51.26% surge in net income for fiscal year 2025, driven by higher sales and menu price adjustments.

ABM Industries announced a 4.6% revenue increase to $8.75 billion in fiscal year 2025, driven by organic growth and strategic acquisitions, alongside a significant increase in operating profit.

Barfresh Food Group Inc. filed an amendment to its 2024 annual report to include detailed information on directors, executive compensation, security ownership, and auditor fees, which were previously omitted.

Toll Brothers, Inc. reported its fiscal year 2025 results, including a 14% decrease in net income to $1.35 billion, and announced its strategic exit from the multifamily development business.

Rithm Acquisition Corp. files its annual 10-K, detailing its SPAC structure, financial position, and strategy to pursue business combinations in financial services, real estate, and digital infrastructure.

Gouverneur Bancorp, Inc. reported a significant increase in net income for the fiscal year ended September 30, 2025, driven by reduced swap losses and gains on securities sales.

cbdMD, Inc. reports reduced operating losses and secures new capital through preferred stock and equity line, while facing significant regulatory challenges in the hemp-derived cannabinoid market.

Track Group, Inc. reported a reduced net loss of $1.88 million in fiscal year 2025, driven by improved operating income and gross margin, despite a 5% revenue decline.

Magyar Bancorp, Inc. announced a 25.4% increase in net income to $9.8 million for fiscal year 2025, driven by higher net interest income and significant loan portfolio growth.

USBC, Inc. has completed a strategic pivot to digital financial technologies, including a Bitcoin treasury strategy and tokenized deposit offering, following a $125 million controlling-interest acquisition.

Bridgeline Digital reported a larger net loss and negative Adjusted EBITDA for fiscal year 2025, despite growth in its core AI-powered products.

Equus Total Return, Inc. reports continued net investment losses and a significant market discount in 2022, while pursuing a strategic transformation from a Business Development Company.